Nelarabine

규격

121032-29-9CAS 번호

642-916-9EC 번호

(2R,3S,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diolIUPAC 명칭

C11H15N5O5화학식

297.27 g/mol분자량

Nelarabine; 121032-29-9; Nelzarabine; Arranon; Atriance; 506U78; 506U; GW-506U78; Attriance; NSC-686673; GW506U78; 2-Amino-6-methoxypurine arabinoside; compound 506U78; Nelarabina; 2-Amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine; DTXSID6046842; NSC-755985; (2R,3S,4S,5R)-2-(2-amino-6-methoxy-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; CHEBI:63612; NSC-759876; 60158CV180; DTXCID4026842; (2R,3S,4S,5R)-2-(hydroxymethyl)-5-(2-imino-6-methoxy-3,9-dihydro-2H-purin-9-yl)oxolane-3,4-diol; nelarabinum; NSC686673; nelarabine injection; RefChem:832139; L01BB07; 2-Amino, 6-Methoxypurine Arabinoside; 642-916-9; 9-beta-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine; (2R,3S,4S,5R)-2-(2-Amino-6-methoxy-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; C11H15N5O5; MFCD00871078; Nelarabine (Arranon); 9H-Purin-2-amine, 9-b-D-arabinofuranosyl-6-methoxy-; (2R,3S,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; GW 506U78; MAY; NCGC00181098-01; S1213; Nelarabine [USAN]; ArranonG; (2R,3S,4S,5R)-2-(2-amino-6-methoxy-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; SMR002544682; Arranon (TN); Nelzarabine (USAN); CAS-121032-29-9; Nelarabine [USAN:INN:BAN]; GW-506U; UNII-60158CV180; Nelarabine [INN]; 9beta-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine; NSC 686673; Nelarabine (Standard); NELARABINE [MI]; NELARABINE [JAN]; NELARABINE [VANDF]; NELARABINE [MART.]; NELARABINE [WHO-DD]; SCHEMBL18820; MLS003915614; MLS004774135; MLS006010906; Nelarabine (JAN/USAN/INN); NELARABINE [EMA EPAR]; GTPL7090; orb1300623; 9-(beta-D-arabinofuranosyl)-6-methoxy-9H-purin-2-amine; CHEMBL1201112; NELARABINE [ORANGE BOOK]; SCHEMBL29374016; EX-A7779L; HMS3715I16; Tox21_112714; BDBM50247985; EBC-11246; HY-13701R; NSC755985; 2-(2-Amino-6-methoxy-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol; AKOS015852325; AKOS015920191; Tox21_112714_1; CCG-267441; CS-1607; DB01280; NN26176; NCGC00274059-01; NCGC00274059-02; AS-47664; BP-58633; HY-13701; SY227007; N1144; N1744; SW218086-2; T6603; D05134; F15095; AB01274773-01; AB01274773_02; EN300-7361965; F093678; SR-01000931847; 9-b-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine; Q1216264; SR-01000931847-3; 2-Amino-6-methoxy-9-b-D-arabinofuranosyl-9 H-purine; 2-Amino-6-methoxy-9-b-D-arabinofuranosyl-9H-purine; 9-|A-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine; BRD-K84466663-001-01-3; BRD-K84466663-001-05-4; 2-Amino-6-methoxy-9-beta-D-arabinofuranosyl-9H-purine; 9-beta -D-arabinofuranosyl-2-amino-6-methoxy-9H-purine; 9-beta-D-arabinofuranosyl-2-amino-6-methoxy-9 H-purine; 9H-Purin-2-amine, 9beta-D-arabinofuranosyl-6-methyl-; 2-Amino-6-methoxy-9-(beta-D-arabinofuranosyl)-9H-purine; 2-AMINO-9-.BETA.-D-ARABINOFURANOSYL-6-METHOXY-9H-PURINE; 9-.BETA.-D-ARABINOFURANOSYL-6-METHOXY-9H-PURIN-2-AMINE; 9H-PURIN-2-AMINE, 9-.BETA.-D-ARABINOFURANOSYL-6-METHOXY-동의어